Andrew J. Schwab, Director at Skye Bioscience, sold SKYE on Aug 18, 2026
Data as of Oct 16
- Traded
- Aug 18, 2026
- Disclosed
- Aug 20, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
SKYE since disclosure
+452.8%
after the sale
Similar stocks (XLV) since disclosure
+2.5%
XLV — its sector index fund
Change in closing price from Aug 20, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLAndrew J. Schwab DirectorSKYE Skye Bioscience, Inc.$2.1Kdisclosed Aug 20 · filed the same day
- ▼ SELLAndrew J. Schwab DirectorSKYE Skye Bioscience, Inc.$371disclosed Aug 20 · filed the same day
- ▼ SELLAndrew J. Schwab DirectorSKYE Skye Bioscience, Inc.$15disclosed Aug 20 · filed the same day
- ▼ SELLAndrew J. Schwab DirectorSKYE Skye Bioscience, Inc.$3.6Kdisclosed Aug 20 · filed 1 day after the trade
- ▼ SELLAndrew J. Schwab DirectorSKYE Skye Bioscience, Inc.$20.1Kdisclosed Aug 20 · filed 1 day after the trade
- ▼ SELLAndrew J. Schwab DirectorSKYE Skye Bioscience, Inc.$143disclosed Aug 20 · filed 1 day after the trade
- ▼ SELLAndrew J. Schwab DirectorSKYE Skye Bioscience, Inc.$96.2Kdisclosed Aug 20 · filed 2 days after the trade
- ▼ SELLAndrew J. Schwab DirectorSKYE Skye Bioscience, Inc.$17.1Kdisclosed Aug 20 · filed 2 days after the trade